Skip to content
Alzey Partners

The lines we represent.

We represent one line today, and we say so plainly. A long brand list tells a manufacturer very little; how a single line is actually run tells them everything. Whose name is on the licence, where the stock sits, who chases the receivables.

This page is the record of the line we carry and of what our network can carry next. It is written for the person deciding whom to hand a market to.

Allurion Technologies Inc.

Obesity and metabolic, under master distribution for Türkiye and the CIS. From the registration file to delivery into an authorised centre and on to post-market vigilance, the chain runs under one agreement; the step-by-step version sits on the Medical page.

Manufacturer
Allurion Technologies Inc.
Lines
Allurion Swallowable Gastric Balloon · Allurion Virtual Care Suite (VCS)
Category
Obesity and metabolic
Relationship
Master Distributor, Türkiye and the CIS
Geography
Türkiye and the CIS
Regulatory
Alzey is the licence holder and the importer; the TİTCK licence and the ÜTS registration sit in Alzey's name
Dated record
Allurion Türkiye
Allurion Program components on a neutral ground: the Smart Capsule with its placement catheter, the balloon, the Smart Scale and the mobile app screen.
Program components: the Smart Capsule with its placement catheter, the balloon, the Smart Scale and the mobile app. The image belongs to Allurion Technologies Inc. and is used solely as a record of the line we represent.

Where the line runs.

In Türkiye we run the operation ourselves. In Kazakhstan, Georgia and Azerbaijan the same model works through a distribution network. Sub-distributors in these markets are structured under the same authority, and training and certification coordination stays with us.

Türkiye — active operationKazakhstan — sub-distributor network activeGeorgia — active marketAzerbaijan — active market

We have room for adjacent categories.

Our network is made of centres working in obesity, metabolic health and aesthetics: hospitals, obesity clinics, physician practices and medical-travel agencies. That composition decides which device lines we can genuinely sell, and the categories below are the ones that sit on top of it.

  1. Obesity and metabolic devices

    The line we carry today. The regulatory work, the field rhythm and the training programme are all built around this category.

  2. Bariatric and endoscopic devices and consumables

    The same physician, often the same procedure day. The counterparty does not change, so the sales cycle sits straight on top of the network we already run.

  3. Body contouring and aesthetic technologies

    Most of the centres we work with run obesity and aesthetics under one roof. These lines follow the relationships we already hold.

  4. Metabolic monitoring and digital health hardware

    Lines that ship follow-up data with the device. We already run programme follow-up and patient communication on systems we wrote ourselves.

  5. Premium device lines aimed at medical travel

    Türkiye draws a strong inbound patient flow for aesthetic and surgical procedures, and that flow makes demand for premium devices partly independent of the local patient economy; the medical-travel channel in our network is open to these lines.

We cannot carry every device line. The composition of the network decides where we can actually sell, so if your line does not fit it, you will hear that in the first conversation.

Let's test whether your line fits this network.

The first conversation covers the category, the regulatory position and a realistic route into the market. Our corporate announcements sit on the News page.